|
WO2000053756A2
(en)
*
|
1999-03-08 |
2000-09-14 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
GB9701684D0
(en)
|
1997-01-28 |
1997-03-19 |
Smithkline Beecham Plc |
Novel compounds
|
|
WO1999066041A1
(en)
|
1998-06-16 |
1999-12-23 |
Human Genome Sciences, Inc. |
94 human secreted proteins
|
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2000070050A1
(en)
*
|
1999-05-14 |
2000-11-23 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US6579520B2
(en)
*
|
1998-05-15 |
2003-06-17 |
Genentech, Inc. |
IL-17 related mammalian cytokine polypeptides (IL-17E)
|
|
US7057017B2
(en)
|
1997-04-16 |
2006-06-06 |
Millennium Pharmaceuticals, Inc. |
Human dickkopf-related protein and nucleic acid molecules and uses therefor
|
|
US6949358B1
(en)
|
1997-06-11 |
2005-09-27 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptor TR9
|
|
US6358508B1
(en)
|
1997-06-11 |
2002-03-19 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor TR9
|
|
AU8693598A
(en)
*
|
1997-08-08 |
1999-03-01 |
University Of Washington |
Isolation of a novel senescence-factor gene, p23
|
|
US20030032102A1
(en)
|
1997-09-18 |
2003-02-13 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030199436A1
(en)
*
|
1997-10-17 |
2003-10-23 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030069178A1
(en)
|
1997-10-17 |
2003-04-10 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6391311B1
(en)
|
1998-03-17 |
2002-05-21 |
Genentech, Inc. |
Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
|
|
US7105640B2
(en)
|
1997-10-17 |
2006-09-12 |
Genentech, Inc. |
Anti-pro792 antibodies
|
|
US6808890B2
(en)
|
1999-07-28 |
2004-10-26 |
Nuvelo, Inc. |
Method of detecting a cancerous cell expressing EGFL6, and EGF mutif protein
|
|
US6392019B1
(en)
|
1997-11-22 |
2002-05-21 |
John Ford |
Antibodies specific for EGF motif proteins
|
|
US8007798B2
(en)
|
1997-11-21 |
2011-08-30 |
Genentech, Inc. |
Treatment of complement-associated disorders
|
|
US7192589B2
(en)
|
1998-09-16 |
2007-03-20 |
Genentech, Inc. |
Treatment of inflammatory disorders with STIgMA immunoadhesins
|
|
US8088386B2
(en)
|
1998-03-20 |
2012-01-03 |
Genentech, Inc. |
Treatment of complement-associated disorders
|
|
CA2309358A1
(en)
*
|
1997-11-21 |
1999-06-03 |
Genentech, Inc. |
A-33 related antigens and their pharmacological uses
|
|
JP2002504308A
(ja)
|
1997-11-22 |
2002-02-12 |
ハイセック インコーポレイテッド |
胎児肝−脾臓のｃＤＮＡライブラリーから得られた新規ＥＧＦモチーフタンパク質
|
|
US7446181B2
(en)
|
1998-01-15 |
2008-11-04 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind human Dickkopf-1 proteins
|
|
US7033772B1
(en)
|
1998-01-15 |
2006-04-25 |
Millennium Pharmaceuticals, Inc. |
Methods of identifying inhibitors of fatty acid transport proteins (FATP)
|
|
US6203979B1
(en)
|
1998-01-16 |
2001-03-20 |
Incyte Pharmaceuticals, Inc. |
Human protease molecules
|
|
US7045333B1
(en)
|
1998-01-16 |
2006-05-16 |
Incyte Corporation |
Human protease molecules
|
|
US6566498B1
(en)
|
1998-02-06 |
2003-05-20 |
Human Genome Sciences, Inc. |
Human serine protease and serpin polypeptides
|
|
DK2016951T3
(da)
|
1998-03-17 |
2012-09-24 |
Genentech Inc |
VEGF- og BMP1-homologe polypeptider
|
|
US7067636B2
(en)
|
1998-05-06 |
2006-06-27 |
Genentech, Inc. |
Anti-pro 1017 antibodies
|
|
US7081521B2
(en)
|
1998-05-06 |
2006-07-25 |
Genentech, Inc. |
Anti-PRO788 antibodies
|
|
US7488795B2
(en)
|
1998-05-07 |
2009-02-10 |
Genentech, Inc. |
PRO846 polypeptides
|
|
US7279553B2
(en)
|
1998-05-13 |
2007-10-09 |
Genentech, Inc. |
PRO1083 polypeptides
|
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
|
EP3112468A1
(en)
*
|
1998-05-15 |
2017-01-04 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
|
EP1865061A3
(en)
*
|
1998-05-15 |
2007-12-19 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
|
EP2333069A3
(en)
|
1998-05-15 |
2011-09-14 |
Genentech, Inc. |
Therapeutic uses of IL-17 homologous polypeptides
|
|
US7019115B2
(en)
|
1998-05-22 |
2006-03-28 |
Genentech, Inc. |
Pro1017 polypeptides
|
|
US6171843B1
(en)
|
1998-06-01 |
2001-01-09 |
Incyte Pharmaceuticals, Inc. |
Human peptidyl-prolyl isomerases
|
|
US6462187B1
(en)
|
2000-06-15 |
2002-10-08 |
Millennium Pharmaceuticals, Inc. |
22109, a novel human thioredoxin family member and uses thereof
|
|
AU4989399A
(en)
*
|
1998-07-15 |
2000-02-07 |
Human Genome Sciences, Inc. |
Bone morphogenic protein
|
|
US7220835B2
(en)
|
1998-07-30 |
2007-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
EP1111060A4
(en)
*
|
1998-08-31 |
2003-01-02 |
Long Yu |
HUMAN LYSOZYME GENE, CODED POLYPEPTIDE AND METHOD FOR THE PRODUCTION THEREOF
|
|
US6699671B1
(en)
|
1998-09-24 |
2004-03-02 |
Pharmacia & Upjohn Company |
Alzheimer's disease secretase, APP substrates therefor, and uses therefor
|
|
US6844148B1
(en)
|
1998-09-24 |
2005-01-18 |
Pharmacia & Upjohn Company |
Alzheimer's disease secretase, APP substrates therefor, and uses therefor
|
|
DK1115874T3
(da)
|
1998-09-24 |
2009-04-20 |
Pharmacia & Upjohn Co Llc |
Alzheimer's sygdom-sekretase
|
|
WO2000020590A2
(en)
*
|
1998-10-06 |
2000-04-13 |
Incyte Pharmaceuticals, Inc. |
G-protein coupled receptor proteins
|
|
US20030203446A1
(en)
|
1998-10-07 |
2003-10-30 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6960433B1
(en)
|
1998-10-19 |
2005-11-01 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
|
|
EP1127122A2
(en)
*
|
1998-10-28 |
2001-08-29 |
Incyte Pharmaceuticals, Inc. |
Growth factor related molecules
|
|
US6432673B1
(en)
|
1998-12-07 |
2002-08-13 |
Zymogenetics, Inc. |
Growth factor homolog ZVEGF3
|
|
WO2000034473A2
(en)
*
|
1998-12-10 |
2000-06-15 |
Zymogenetics, Inc. |
Seven transmembrane domain receptor zsig56
|
|
CA2450402A1
(en)
*
|
1998-12-22 |
2000-06-29 |
Genentech, Inc. |
Methods and compositions for inhibiting cancer cell growth comprising pro224
|
|
WO2000039284A1
(en)
*
|
1998-12-30 |
2000-07-06 |
Millennium Pharmaceuticals, Inc. |
Secreted proteins and nucleic acids encoding them
|
|
US7456007B1
(en)
|
1998-12-31 |
2008-11-25 |
Elan Pharmaceuticals, Inc. |
β-secretase enzyme compositions and methods
|
|
US7115410B1
(en)
|
1999-02-10 |
2006-10-03 |
Elan Pharmaceuticals, Inc. |
β-secretase enzyme compositions and methods
|
|
AU4000900A
(en)
|
1999-02-10 |
2000-08-29 |
Elan Pharmaceuticals, Inc. |
Beta-secretase enzyme compositions and methods
|
|
AU2224800A
(en)
*
|
1999-03-08 |
2000-09-28 |
Genentech Inc. |
Compositions and methods for the treatment of tumor
|
|
AU2596700A
(en)
*
|
1999-03-08 |
2000-09-28 |
Genentech Inc. |
Promotion or inhibition of angiogenesis and cardiovascularization
|
|
EP1220905A2
(en)
*
|
1999-03-08 |
2002-07-10 |
Genentech Inc. |
Composition and methods for the treatment of immune related diseases
|
|
AU2399300A
(en)
*
|
1999-03-08 |
2000-09-28 |
Genentech Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
|
AU3737500A
(en)
*
|
1999-03-12 |
2000-09-28 |
Genentech Inc. |
Method of preventing the death of retinal neurons and treating ocular diseases
|
|
WO2000059940A2
(en)
*
|
1999-04-06 |
2000-10-12 |
Eli Lilly And Company |
Platelet-derived growth factor related gene and protein
|
|
AU782985B2
(en)
*
|
1999-04-09 |
2005-09-15 |
Curagen Corporation |
Novel human proteins and polynucleotides encoding them
|
|
US7214656B2
(en)
|
1999-04-28 |
2007-05-08 |
Genentech, Inc. |
PRO792 polypeptides
|
|
WO2000068247A2
(en)
*
|
1999-05-07 |
2000-11-16 |
Human Genome Sciences, Inc. |
Serine proteases
|
|
AU4640600A
(en)
*
|
1999-05-11 |
2000-11-21 |
Eli Lilly And Company |
Amyloid precursor protein protease and related nucleic acid compounds
|
|
CN1244584A
(zh)
*
|
1999-05-14 |
2000-02-16 |
北京医科大学 |
具有免疫细胞趋化和造血刺激活性的趋化因子
|
|
WO2001004301A1
(fr)
*
|
1999-07-08 |
2001-01-18 |
Helix Research Institute |
Proteine transporteuse d'acides gras et gene codant cette proteine
|
|
US7001766B2
(en)
|
1999-07-20 |
2006-02-21 |
Curagen Corporation |
Nucleic acid sequences encoding human angiopoietin-like polypeptides
|
|
KR100543857B1
(ko)
*
|
1999-09-01 |
2006-01-23 |
제넨테크, 인크. |
혈관신생 및 심혈관형성의 촉진 또는 억제
|
|
US6429303B1
(en)
|
1999-09-03 |
2002-08-06 |
Curagen Corporation |
Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same
|
|
AU7337400A
(en)
*
|
1999-09-03 |
2001-04-10 |
Human Genome Sciences, Inc. |
B7-like polynucleotides, polypeptides, and antibodies
|
|
CA2384749A1
(en)
*
|
1999-09-13 |
2001-03-22 |
Curagen Corporation |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
|
EP1218503A2
(en)
*
|
1999-09-23 |
2002-07-03 |
Whitehead Institute For Biomedical Research |
Fatty acid transport proteins
|
|
US6780627B1
(en)
|
2000-01-31 |
2004-08-24 |
Millennium Pharmaceuticals, Inc. |
22438, 23553, 25278, and 26212 novel human sulfatases
|
|
WO2001023569A1
(en)
*
|
1999-09-29 |
2001-04-05 |
Hyseq, Inc. |
Cytokine receptor materials and methods
|
|
US6893637B1
(en)
|
1999-10-21 |
2005-05-17 |
Zymogenetics, Inc. |
Method of treating fibrosis
|
|
CA2388914A1
(en)
*
|
1999-11-12 |
2001-05-17 |
Human Genome Sciences, Inc. |
15 human secreted proteins
|
|
EP1230349B1
(en)
|
1999-11-18 |
2007-06-13 |
Dendreon Corporation |
Nucleic acids encoding endotheliases, endotheliases and uses thereof
|
|
US7514408B1
(en)
|
1999-12-02 |
2009-04-07 |
Elan Pharmaceuticals, Inc. |
β-secretase enzyme compositions and methods
|
|
US6682902B2
(en)
|
1999-12-16 |
2004-01-27 |
Schering Aktiengesellschaft |
DNA encoding a novel RG1 polypeptide
|
|
JP2016047051A
(ja)
*
|
1999-12-23 |
2016-04-07 |
ジェネンテック， インコーポレイテッド |
Ｉｌ−１７相同的ポリペプチドとその治療上の用途
|
|
US6610286B2
(en)
|
1999-12-23 |
2003-08-26 |
Zymogenetics, Inc. |
Method for treating inflammation using soluble receptors to interleukin-20
|
|
CA2402563A1
(en)
*
|
1999-12-23 |
2001-07-26 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
|
ES2458349T3
(es)
*
|
1999-12-23 |
2014-05-05 |
Genentech, Inc. |
Polipéptidos homólogos IL-17 y usos terapéuticos de los mismos
|
|
AU783473B2
(en)
*
|
1999-12-23 |
2005-10-27 |
Zymogenetics Inc. |
Soluble interleukin-20 receptor
|
|
US7122632B2
(en)
|
1999-12-23 |
2006-10-17 |
Zymogenetics, Inc. |
Soluble Interleukin-20 receptor
|
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
|
WO2001049707A1
(en)
*
|
2000-01-05 |
2001-07-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Gene involved in mineral deposition and uses thereof
|
|
SK9992002A3
(en)
*
|
2000-01-12 |
2003-05-02 |
Univ Yale |
Nogo receptor-mediated blockade of axonal growth
|
|
US7119165B2
(en)
|
2000-01-12 |
2006-10-10 |
Yale University |
Nogo receptor-mediated blockade of axonal growth
|
|
AU2001233702A1
(en)
*
|
2000-01-25 |
2001-08-07 |
Novartis Ag |
Disease-associated gene
|
|
DE60143880D1
(de)
*
|
2000-02-03 |
2011-03-03 |
Dendreon Corp |
Nukleinsäuren, welche für tramsmembran serin proteasen kodieren, die kodierten proteine und darauf basierende methoden
|
|
US6653448B1
(en)
*
|
2000-03-29 |
2003-11-25 |
Curagen Corporation |
Wnt-7B-like polypeptides and nucleic acids encoding same
|
|
US20020156005A1
(en)
*
|
2000-09-25 |
2002-10-24 |
Meyers Rachel E. |
m32404, a novel human trypsin and uses thereof
|
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
|
WO2001079466A2
(en)
*
|
2000-04-18 |
2001-10-25 |
Bayer Aktiengesellschaft |
Regulation of human epithin-like serine protease
|
|
AU2001259271A1
(en)
|
2000-04-28 |
2001-11-12 |
Millennium Pharmaceuticals, Inc. |
14094, a novel human trypsin family member and uses thereof
|
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030031675A1
(en)
|
2000-06-06 |
2003-02-13 |
Mikesell Glen E. |
B7-related nucleic acids and polypeptides useful for immunomodulation
|
|
US20020168713A1
(en)
*
|
2000-06-06 |
2002-11-14 |
Curtis Rory A.J. |
46980, a novel human neuroligin family member and uses thereof
|
|
MXPA02012106A
(es)
|
2000-06-06 |
2003-06-06 |
Bristol Myers Squibb Co |
Polipeptidos y acidos nucleicos relacionados con b7 empleados para inmunomodulacion.
|
|
CA2412211A1
(en)
*
|
2000-06-23 |
2002-01-03 |
Genetech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
|
EP2275549A1
(en)
*
|
2000-06-23 |
2011-01-19 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
|
AU2001271973A1
(en)
*
|
2000-07-20 |
2002-02-05 |
Kevin P. Baker |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
|
JP2015037408A
(ja)
*
|
2000-07-20 |
2015-02-26 |
ジェネンテック， インコーポレイテッド |
血管形成に関連する障害を診断及び治療するための組成物と方法
|
|
EP1305417A2
(en)
*
|
2000-07-21 |
2003-05-02 |
Bristol-Myers Squibb Company |
Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof
|
|
ES2381650T3
(es)
|
2000-08-08 |
2012-05-30 |
Zymogenetics, Inc. |
Receptores de citoquinas Zcytor11 solubles
|
|
JP2004520806A
(ja)
*
|
2000-08-24 |
2004-07-15 |
ジェネンテック・インコーポレーテッド |
腫瘍の診断と治療のための組成物と方法
|
|
CA2420193A1
(en)
*
|
2000-08-24 |
2002-02-28 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
US20040077043A1
(en)
*
|
2000-09-12 |
2004-04-22 |
Hiroshi Watarai |
Novel dendritic cell wall membrane and use thereof
|
|
DK1351703T3
(da)
|
2000-09-15 |
2006-11-27 |
Zymogenetics Inc |
Anvendelse af et polypeptid omfattende det ekstracellulære domæne af IL-20RA og IL-20RB til behandling af inflammation
|
|
EP1322659A4
(en)
*
|
2000-09-20 |
2005-01-26 |
Human Genome Sciences Inc |
21 HUMANE SECRET PROTEINS
|
|
CA2421249A1
(en)
*
|
2000-09-20 |
2002-03-28 |
Human Genome Sciences, Inc. |
21 human secreted proteins
|
|
ES2341608T3
(es)
|
2000-10-06 |
2010-06-23 |
Yale University |
Homologos del receptor de nogo.
|
|
EP1201681A1
(en)
|
2000-10-30 |
2002-05-02 |
Millennium Pharmaceuticals, Inc. |
"Fail" molecules and uses thereof
|
|
EP1790728B1
(en)
*
|
2000-11-06 |
2010-09-08 |
Cancer Research Technology Limited |
Imaging, diagnosis and treatment of disease
|
|
US20020111302A1
(en)
*
|
2000-11-30 |
2002-08-15 |
Y. Tom Tang |
Novel nucleic acids and polypeptides
|
|
WO2002057448A1
(en)
*
|
2000-12-27 |
2002-07-25 |
Daiichi Fine Chemical Co., Ltd. |
Novel peptides and activities thereof
|
|
AU2002305052A1
(en)
|
2001-03-13 |
2002-09-24 |
Corvas International, Inc. |
Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
|
|
AU2002254357A1
(en)
|
2001-03-22 |
2002-10-08 |
Dendreon Corporation |
Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
|
|
US7105333B2
(en)
|
2001-03-27 |
2006-09-12 |
Deadreon Corporation |
Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
|
|
EP2280030A3
(en)
|
2001-04-10 |
2011-06-15 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
WO2002092841A2
(en)
|
2001-05-14 |
2002-11-21 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
|
|
US20040038860A1
(en)
|
2002-05-17 |
2004-02-26 |
Allen Kristina M. |
Reagents and methods for modulating dkk-mediated interactions
|
|
PL370105A1
(en)
*
|
2001-05-25 |
2005-05-16 |
Amgen, Inc. |
B7 related protein-2 molecules and uses thereof
|
|
US7125663B2
(en)
|
2001-06-13 |
2006-10-24 |
Millenium Pharmaceuticals, Inc. |
Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
|
|
WO2003002765A2
(en)
*
|
2001-06-27 |
2003-01-09 |
Cancer Research Technology Limited |
Methods for the diagnosis of cancer based on the obcam and ntm genes
|
|
AU2002315525A1
(en)
*
|
2001-07-03 |
2003-01-21 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding a transmembrane serine protease 20, the encoded polypeptides and methods based thereon
|
|
WO2003008589A1
(en)
*
|
2001-07-18 |
2003-01-30 |
Asahi Kasei Kabushiki Kaisha |
Elk1 PHOSPHORYLATION-ASSOCIATED GENE
|
|
JP2005508171A
(ja)
*
|
2001-11-02 |
2005-03-31 |
タノックス インコーポレーテッド |
Ｂ細胞悪性病変の診断及び予防に用いるためのｂ細胞リンパ腫特異抗原
|
|
IL161978A0
(en)
|
2001-12-17 |
2005-11-20 |
Zymogenetics Inc |
Method for treating cervical cancer
|
|
EP1562969A4
(en)
*
|
2002-03-28 |
2006-07-05 |
Bristol Myers Squibb Co |
NEW HUMAN ZELLOBERGLINE PROTEIN WITH IMMUNODOBULIN FOLDING PEN, BGS-19
|
|
AU2003238178A1
(en)
|
2002-05-29 |
2003-12-12 |
Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung |
Pancreas-specific proteins
|
|
EP1565489B1
(en)
|
2002-06-19 |
2010-11-17 |
Raven Biotechnologies, Inc. |
Internalizing antibodies specific for the RAAG10 cell surface target
|
|
WO2004046191A2
(en)
|
2002-11-20 |
2004-06-03 |
Cancer Research Technology Limited |
Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis
|
|
US20040203132A1
(en)
|
2003-02-28 |
2004-10-14 |
Cognetix, Inc. |
Conus protein disulfide isomerase
|
|
AU2004223837C1
(en)
|
2003-03-24 |
2012-03-15 |
Zymogenetics, Inc. |
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
|
|
WO2005010048A2
(en)
|
2003-07-22 |
2005-02-03 |
Schering Aktiengesellschaft |
Rg1 antibodies and uses thereof
|
|
US7294704B2
(en)
|
2003-08-15 |
2007-11-13 |
Diadexus, Inc. |
Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
|
|
CA2542546A1
(en)
|
2003-11-21 |
2005-06-09 |
Zymogenetics, Inc. |
Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation
|
|
US7867699B2
(en)
|
2004-03-23 |
2011-01-11 |
Wyeth |
Method of synthesizing and purifying Dkk proteins and Dkk proteins obtained thereby
|
|
WO2005117968A2
(en)
|
2004-04-14 |
2005-12-15 |
Genentech, Inc. |
Compositions and methods comprising an egfl7 antagonist for modulating vascular development
|
|
JP2007536931A
(ja)
*
|
2004-05-12 |
2007-12-20 |
ジェネンテック・インコーポレーテッド |
新規の遺伝子破壊、組成物およびそれらに関連する方法
|
|
DK1773884T3
(da)
|
2004-08-03 |
2012-05-21 |
Innate Pharma |
Terapeutiske og diagnostiske fremgangsmåder og sammensætninger til targeting af 4ig-b7-h3 og dets tilsvarende nk-celle-receptor
|
|
CA2574881C
(en)
|
2004-08-04 |
2013-01-08 |
Amgen Inc. |
Antibodies to dkk-1
|
|
ES2347672T3
(es)
|
2004-10-22 |
2010-11-03 |
Zymogenetics, Inc. |
Anticuerpos dirigidos contra il-22ra y compañeros de union procedimientos de uso en enefermedades inflamatorias.
|
|
EP1662261B1
(de)
|
2004-11-25 |
2008-04-09 |
Roche Diagnostics GmbH |
Vorrichtung zum Analysieren von Proben
|
|
CN101124338B
(zh)
|
2004-11-29 |
2011-05-04 |
雷根斯堡大学临床中心 |
用于检测甲基化dna的试剂盒和方法
|
|
AU2005308918B2
(en)
|
2004-11-29 |
2012-09-27 |
Sequenom, Inc. |
Means and methods for detecting methylated DNA
|
|
US7893032B2
(en)
|
2005-07-07 |
2011-02-22 |
Yale University |
NgR variants and compositions thereof for suppressing axonal growth inhibition
|
|
DE602006020923D1
(de)
|
2005-08-16 |
2011-05-05 |
Novozymes As |
Polypeptide von Stammbakterien SP P203
|
|
NZ594285A
(en)
|
2005-11-04 |
2013-02-22 |
Genentech Inc |
USE OF COMPLEMENT PATHWAY INHIBITOR ANTIBODY AGAINST C5a TO TREAT OCULAR DISEASES
|
|
WO2007081608A2
(en)
*
|
2005-11-21 |
2007-07-19 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
|
US7776573B2
(en)
|
2006-06-01 |
2010-08-17 |
Genentech, Inc. |
Crystal structure of CRIg and C3b:CRIg complex
|
|
WO2008003748A2
(en)
*
|
2006-07-07 |
2008-01-10 |
Novo Nordisk A/S |
Cd300lg polypeptides and their use in treating autoimmune diseases
|
|
CL2007003161A1
(es)
|
2006-11-02 |
2008-05-30 |
Genentech Inc |
Anticuerpos anti-factor d; acidos nucleicos que los codifican; vector y linea celular que los comprenden; metodo de produccion; composicion farmaceutica que comprende a los anticuerpos; y su uso para tratar trastornos mediados por el complemento como
|
|
WO2008100805A2
(en)
|
2007-02-09 |
2008-08-21 |
Genentech, Inc. |
Anti-robo4 antibodies and uses therefor
|
|
JP2010133705A
(ja)
*
|
2007-03-16 |
2010-06-17 |
Perseus Proteomics Inc |
癌の診断薬及び治療薬
|
|
AR066660A1
(es)
|
2007-05-23 |
2009-09-02 |
Genentech Inc |
Prevencion y tratamiento de condiciones del ojo asociadas con su complemento
|
|
CN102046655B
(zh)
|
2008-04-02 |
2016-09-14 |
宏观基因有限公司 |
Bcr-复合体-特异性抗体和其使用方法
|
|
CR20170001A
(es)
|
2008-04-28 |
2017-08-10 |
Genentech Inc |
Anticuerpos anti factor d humanizados
|
|
KR20150002874A
(ko)
|
2008-05-05 |
2015-01-07 |
노비뮨 에스 에이 |
항-ｉｌ-１７ａ／ｉｌ-１７ｆ 교차-반응성 항체 및 그의 사용 방법
|
|
SG190596A1
(en)
|
2008-05-06 |
2013-06-28 |
Genentech Inc |
Affinity matured crig variants
|
|
AR075989A1
(es)
|
2009-04-10 |
2011-05-11 |
Lilly Co Eli |
Anticuerpo dkk -1 (dickkopf-1) humano disenado por ingenieria
|
|
SG175276A1
(en)
|
2009-05-05 |
2011-11-28 |
Novimmune Sa |
Anti-il-17f antibodies and methods of use thereof
|
|
AU2010245739B2
(en)
|
2009-05-08 |
2013-07-11 |
Genentech, Inc. |
Humanized anti-EGFL7 antibodies and methods using same
|
|
AU2010246981B2
(en)
|
2009-05-12 |
2013-12-19 |
Pfizer Inc. |
Blocking anti-Dkk-1 antibodies and their uses
|
|
EP3381937A3
(en)
|
2009-08-13 |
2018-10-31 |
The Johns Hopkins University |
Methods of modulating immune function
|
|
AU2011219715B2
(en)
|
2010-02-26 |
2014-12-11 |
Novo Nordisk A/S |
Stable antibody containing compositions
|
|
PH12012501751A1
(en)
|
2010-03-04 |
2012-11-12 |
Macrogenics Inc |
Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
|
|
LT2542256T
(lt)
|
2010-03-04 |
2019-10-25 |
Macrogenics Inc |
Su b7-h3 reaguojantys antikūnai, jų imunologiškai aktyvūs fragmentai ir jų naudojimas
|
|
JP6294075B2
(ja)
|
2010-05-28 |
2018-03-14 |
ノヴォ ノルディスク アー／エス |
抗体及び防腐剤を含む安定した多用量組成物
|
|
US9487587B2
(en)
|
2013-03-05 |
2016-11-08 |
Macrogenics, Inc. |
Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
|
|
EP2968391A1
(en)
|
2013-03-13 |
2016-01-20 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
|
JP6463359B2
(ja)
|
2013-08-12 |
2019-01-30 |
ジェネンテック， インコーポレイテッド |
補体関連病態を治療するための組成物及び方法
|
|
MX2016014160A
(es)
|
2014-05-01 |
2017-02-16 |
Genentech Inc |
Variantes del anticuerpo anti-factor d y sus usos.
|
|
EP3368074A2
(en)
|
2015-10-30 |
2018-09-05 |
Hoffmann-La Roche AG |
Anti-factor d antibodies and conjugates
|
|
EP3368090A1
(en)
|
2015-10-30 |
2018-09-05 |
H. Hoffnabb-La Roche Ag |
Anti-factor d antibody variant conjugates and uses thereof
|
|
CA3020864A1
(en)
|
2016-04-15 |
2017-10-19 |
Macrogenics, Inc. |
Novel b7-h3-binding molecules, antibody drug conjugates thereof and methods of use thereof
|
|
SG11201906735RA
(en)
*
|
2017-01-23 |
2019-08-27 |
Regeneron Pharma |
Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof
|
|
EP4685243A2
(en)
|
2017-10-11 |
2026-01-28 |
Regeneron Pharmaceuticals, Inc. |
Inhibition of hsd17b13 in the treatment of liver disease in patients expressing the pnpla3 i148m variation
|
|
CN109708935A
(zh)
*
|
2018-12-15 |
2019-05-03 |
济南艾迪康医学检验中心有限公司 |
一种高分辨外周血染色体g带的制作方法
|